AR057909A1 - Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. - Google Patents
Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.Info
- Publication number
- AR057909A1 AR057909A1 ARP060105063A ARP060105063A AR057909A1 AR 057909 A1 AR057909 A1 AR 057909A1 AR P060105063 A ARP060105063 A AR P060105063A AR P060105063 A ARP060105063 A AR P060105063A AR 057909 A1 AR057909 A1 AR 057909A1
- Authority
- AR
- Argentina
- Prior art keywords
- intermediate compound
- related compounds
- compound derived
- sulfonic ester
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/75—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicacion 1: Un compuesto de formula (1) en donde R es un grupo alquilo C1-4 recto o ramificado y es preferiblemente un grupo metilo. Reivindicacion 2: El proceso que comprende hacer reaccionar el compuesto de formula (4) o de formula (3) o una sal de adicion de ácido del mismo con un compuesto de formula (1) de la reivindicacion 1, para formar un compuesto de formula (2) o (5) en donde R es un grupo alquilo C1-4.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73775205P | 2005-11-18 | 2005-11-18 | |
US79442906P | 2006-04-24 | 2006-04-24 | |
US82438206P | 2006-09-01 | 2006-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057909A1 true AR057909A1 (es) | 2007-12-26 |
Family
ID=37685804
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105062A AR057908A1 (es) | 2005-11-18 | 2006-11-17 | Proceso para preparar montelukast e intermediarios del mismo |
ARP060105063A AR057909A1 (es) | 2005-11-18 | 2006-11-17 | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. |
ARP060105061A AR056815A1 (es) | 2005-11-18 | 2006-11-17 | PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105062A AR057908A1 (es) | 2005-11-18 | 2006-11-17 | Proceso para preparar montelukast e intermediarios del mismo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105061A AR056815A1 (es) | 2005-11-18 | 2006-11-17 | PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST |
Country Status (12)
Country | Link |
---|---|
US (5) | US7786138B2 (es) |
EP (3) | EP1948610A2 (es) |
JP (1) | JP2009515922A (es) |
AR (3) | AR057908A1 (es) |
AT (1) | ATE497493T1 (es) |
AU (3) | AU2006314729A1 (es) |
CA (3) | CA2598093A1 (es) |
DE (1) | DE602006019979D1 (es) |
IL (1) | IL185129A0 (es) |
NO (1) | NO20074188L (es) |
PT (1) | PT1954679E (es) |
WO (3) | WO2007057227A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1831171A4 (en) * | 2004-11-19 | 2010-09-15 | Matrix Lab Ltd | PROCESS FOR THE PREPARATION OF NEW MONTELUKAST SODIUM AMORPHOUS |
ES2358923T3 (es) | 2005-07-05 | 2011-05-16 | Teva Pharmaceutical Industries, Ltd. | Purificación de montelukast. |
AR057908A1 (es) * | 2005-11-18 | 2007-12-26 | Synthon Bv | Proceso para preparar montelukast e intermediarios del mismo |
EP2014650A1 (en) * | 2007-07-13 | 2009-01-14 | Lonza Ag | Process and intermediate for the production of an intermediate in the production of montelukast |
ES2320077B1 (es) * | 2007-07-31 | 2010-02-26 | Moehs Iberica, S.L. | Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo. |
EP2276739A1 (en) * | 2008-04-25 | 2011-01-26 | Synthon B.V. | Process for making montelukast intermediates |
EP2552892A1 (en) | 2010-03-31 | 2013-02-06 | KRKA, D.D., Novo Mesto | Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein |
WO2011139899A2 (en) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
TWI450275B (zh) * | 2010-05-19 | 2014-08-21 | Wistron Corp | 可提升寫入保護之記憶體系統及相關方法 |
US8471030B2 (en) | 2010-12-06 | 2013-06-25 | Orochem Technologies Inc. | Purification of montelukast using simulated moving bed |
EP2502910A1 (en) * | 2011-03-15 | 2012-09-26 | Laboratorios Lesvi, S.L. | Camphorsulfonic salt of a key Montelukast intermediate |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU199796B (en) * | 1985-08-06 | 1990-03-28 | Boehringer Biochemia Srl | Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds |
CA2038178A1 (en) | 1990-04-05 | 1991-10-06 | Carl C. Greco | Niobium alkoxyalkoxides and process for formation |
US5266568A (en) * | 1990-10-12 | 1993-11-30 | Merck Frosst Canada, Inc. | Hydroxyalkylquinoline ether acids as leukotriene antagonists |
EP0480716A1 (en) * | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
US5565473A (en) | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
HU222344B1 (hu) | 1990-10-12 | 2003-06-28 | Merck Frosst Canada & Co. | Eljárás telítetlen hidroxi-alkil-kinolinsavak, és ezeket tartalmazó gyógyszerkészítmények előállítására |
US5856322A (en) | 1990-10-12 | 1999-01-05 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
US5270324A (en) | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
TW448160B (en) | 1993-12-28 | 2001-08-01 | Merck & Co Inc | Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists |
GB9423511D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
US5585115A (en) | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
US5523477A (en) | 1995-01-23 | 1996-06-04 | Merck & Co., Inc. | Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid |
US5869673A (en) * | 1997-02-28 | 1999-02-09 | Merck & Co., Inc. | Process for 3-(2-(7-chloro-2-quinolinyl)ethenyl) - benzaldehyde |
CN1420113A (zh) * | 2001-11-16 | 2003-05-28 | 北京上地新世纪生物医药研究所 | 孟鲁司特钠的制备方法及其制备中间体 |
CN1171873C (zh) * | 2001-12-26 | 2004-10-20 | 北京上地新世纪生物医药研究所 | 一种孟鲁司特钠的制备方法及其制备中间体 |
US20050107612A1 (en) * | 2002-12-30 | 2005-05-19 | Dr. Reddy's Laboratories Limited | Process for preparation of montelukast and its salts |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
CA2541994A1 (en) * | 2003-10-10 | 2005-05-06 | Arjanne Overeem | Solid-state montelukast |
EP1708708A1 (en) * | 2004-01-30 | 2006-10-11 | Teva Pharmaceutical Industries Ltd. | Montelukast free acid polymorphs |
US7189853B2 (en) * | 2004-04-15 | 2007-03-13 | Dr. Reddy's Laboratories Limited | Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts |
US7501517B2 (en) * | 2004-04-30 | 2009-03-10 | Synthon Ip, Inc. | Process for making montelukast and intermediates therefor |
US7829716B2 (en) * | 2004-04-30 | 2010-11-09 | Synthon Pharmaceuticals, Inc. | Process for making montelukast and intermediates therefor |
DE602004031678D1 (de) * | 2004-07-19 | 2011-04-14 | Matrix Lab Ltd | Verfahren zur herstellung von montelukast und salzen davon |
ITMI20050247A1 (it) * | 2005-02-18 | 2006-08-19 | Chemi Spa | Processo per la preparazione di montelukast |
AR057908A1 (es) * | 2005-11-18 | 2007-12-26 | Synthon Bv | Proceso para preparar montelukast e intermediarios del mismo |
-
2006
- 2006-11-17 AR ARP060105062A patent/AR057908A1/es not_active Application Discontinuation
- 2006-11-17 AR ARP060105063A patent/AR057909A1/es not_active Application Discontinuation
- 2006-11-17 AR ARP060105061A patent/AR056815A1/es not_active Application Discontinuation
- 2006-11-20 DE DE602006019979T patent/DE602006019979D1/de active Active
- 2006-11-20 AU AU2006314729A patent/AU2006314729A1/en not_active Abandoned
- 2006-11-20 EP EP06818691A patent/EP1948610A2/en not_active Withdrawn
- 2006-11-20 WO PCT/EP2006/011133 patent/WO2007057227A1/en active Application Filing
- 2006-11-20 CA CA002598093A patent/CA2598093A1/en not_active Abandoned
- 2006-11-20 US US11/561,732 patent/US7786138B2/en not_active Expired - Fee Related
- 2006-11-20 CA CA002629840A patent/CA2629840A1/en not_active Abandoned
- 2006-11-20 CA CA002629834A patent/CA2629834A1/en not_active Abandoned
- 2006-11-20 AU AU2006314726A patent/AU2006314726A1/en not_active Abandoned
- 2006-11-20 AU AU2006314728A patent/AU2006314728A1/en not_active Abandoned
- 2006-11-20 US US11/561,724 patent/US7601741B2/en not_active Expired - Fee Related
- 2006-11-20 EP EP06818694A patent/EP1954679B1/en not_active Not-in-force
- 2006-11-20 PT PT06818694T patent/PT1954679E/pt unknown
- 2006-11-20 EP EP06818693A patent/EP1960362A1/en not_active Withdrawn
- 2006-11-20 US US11/561,689 patent/US7476748B2/en not_active Expired - Fee Related
- 2006-11-20 AT AT06818694T patent/ATE497493T1/de not_active IP Right Cessation
- 2006-11-20 WO PCT/EP2006/011127 patent/WO2007057225A2/en active Application Filing
- 2006-11-20 JP JP2008540534A patent/JP2009515922A/ja not_active Withdrawn
- 2006-11-20 WO PCT/EP2006/011134 patent/WO2007057228A1/en active Application Filing
-
2007
- 2007-08-08 IL IL185129A patent/IL185129A0/en unknown
- 2007-08-15 NO NO20074188A patent/NO20074188L/no not_active Application Discontinuation
-
2008
- 2008-12-12 US US12/334,124 patent/US20090093636A1/en not_active Abandoned
-
2009
- 2009-10-09 US US12/576,773 patent/US20100099879A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006314726A1 (en) | 2007-05-24 |
US20070135480A1 (en) | 2007-06-14 |
AU2006314729A1 (en) | 2007-05-24 |
US20070135642A1 (en) | 2007-06-14 |
ATE497493T1 (de) | 2011-02-15 |
EP1960362A1 (en) | 2008-08-27 |
WO2007057225A2 (en) | 2007-05-24 |
US20100099879A1 (en) | 2010-04-22 |
US7786138B2 (en) | 2010-08-31 |
JP2009515922A (ja) | 2009-04-16 |
WO2007057227A1 (en) | 2007-05-24 |
AR057908A1 (es) | 2007-12-26 |
US7476748B2 (en) | 2009-01-13 |
EP1948610A2 (en) | 2008-07-30 |
US7601741B2 (en) | 2009-10-13 |
US20090093636A1 (en) | 2009-04-09 |
AU2006314728A1 (en) | 2007-05-24 |
US20070135643A1 (en) | 2007-06-14 |
WO2007057228A1 (en) | 2007-05-24 |
PT1954679E (pt) | 2011-05-05 |
EP1954679A1 (en) | 2008-08-13 |
NO20074188L (no) | 2008-08-13 |
WO2007057225A3 (en) | 2007-07-26 |
CA2629840A1 (en) | 2007-05-24 |
AR056815A1 (es) | 2007-10-24 |
EP1954679B1 (en) | 2011-02-02 |
CA2629834A1 (en) | 2007-05-24 |
DE602006019979D1 (de) | 2011-03-17 |
CA2598093A1 (en) | 2007-05-24 |
IL185129A0 (en) | 2007-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057909A1 (es) | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. | |
CY1110800T1 (el) | Μεθανοσουλφονικα αλατα αβιρατερονης-3-εστερων και ανακτηση αλατων αβιρατερονης-3-εστερων απο διαλυμα σε μεθυλο τριτ-βουτυλαιθερα | |
ME01992B (me) | Jedinjenje diarilhidantoina | |
MA31574B1 (fr) | Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf | |
ES2570184T3 (es) | Compuestos para dirigir la administración de fármacos y potenciar la actividad de ARNip | |
RS52823B (en) | NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
AR059010A1 (es) | 6-( aril polisustituido )-4- aminopicolinatos y su uso como herbicidas | |
TW200736221A (en) | Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor | |
RS52214B (en) | HDAC INHIBITOR PHARMACEUTICAL FORMULATIONS | |
AR048875A1 (es) | Un proceso para preparar montelukast y compuestos intermedios para el mismo | |
RS53003B (en) | C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS | |
EA201690072A1 (ru) | Состав, содержащий гиполипидемическое средство | |
WO2007083090A3 (en) | Process for the preparation of uracil derivatives | |
EA200800777A1 (ru) | Применение сложных эфиров молочной кислоты для улучшения действия пестицидов | |
RS52171B (en) | NALMEFEN DI-ESTER PRODUCTS | |
ATE477234T1 (de) | Synthese von phenolischen estern von hydroxymethylphenolen | |
AR063747A1 (es) | Definilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas | |
CR11463A (es) | Compuestos de piridilmetil-sulfonamida | |
EA200802142A1 (ru) | Цинковая соль розувастатина | |
AR064658A1 (es) | Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma | |
DE602006018065D1 (de) | Salze von 9-oxoacridin-10-essigsäure mit 1-alkylamino-1-desoxypolyolen | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
EA201071424A1 (ru) | Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина | |
AR057555A1 (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo | |
AR051936A1 (es) | Proceso para la preparacion de pirazoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |